SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ZIM Laboratories inks pact with Globalpharma to commercialize oral thin film products

09 Apr 2025 Evaluate

ZIM Laboratories has entered into a dossier license, product supply, and technology know-how license agreement with Globalpharma Co (L.L.C.). This partnership encompasses dossier licensing, bulk product supply, and the licensing of the company’s proprietary oral thin film technology platform, ThinOral. 

Under the agreement, Globalpharma will register and commercialize 10 OTF-based Pharmaceutical and Nutraceutical products developed by the company, catering to regional patient needs with advanced, user-friendly dosage forms. Initially, the company will supply bulk products while providing complete regulatory support for market registration in the UAE. Post-approval, the company will deliver ready-to-use powder mixes, enabling Globalpharma to undertake localized manufacturing and marketing of the finished formulations.

The partnership marks a pivotal milestone in ZIM Labs’ mission to make differentiated formulations globally accessible and reinforces its presence in the rapidly growing Middle Eastern Pharmaceutical market.

ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develop generic pharmaceutical products.


Zim Laboratories Share Price

108.35 5.35 (5.19%)
11-May-2026 10:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1874.70
Dr. Reddys Lab 1285.60
Cipla 1335.00
Zydus Lifesciences 938.25
Lupin 2250.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×